These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 4114051)

  • 21. [Role of antibiotics in the ecology of cholera vibrios].
    Podosinnikova LS
    Antibiotiki; 1977 Apr; 22(4):371-7. PubMed ID: 329747
    [No Abstract]   [Full Text] [Related]  

  • 22. The in vitro sensitivity of Bibrio Cholerae strains to sulfamethopyrazine and aminosidine and data on the transfer of drug resistance from E. coli to some cholera agent strains.
    Ruiz Merino J; Buogo A
    Farmaco Prat; 1973 Apr; 28(4):210-7. PubMed ID: 4572388
    [No Abstract]   [Full Text] [Related]  

  • 23. [Bacteriological aspects of cholera in Chad (1991 and 1994 epidemics)].
    Massenet D; Djerane L; Gamougane K; Fournier JM
    Bull Soc Pathol Exot; 1995 Mar; 88(4):203-5. PubMed ID: 8640086
    [No Abstract]   [Full Text] [Related]  

  • 24. [Variability of Vibrio cholerae as affected by subbacteriostatic concentrations of antibiotics].
    Andrusenko IT; Ved'mina EA; Givental' NI; Pasternak NA; Aleksandrova IK
    Antibiotiki; 1984 Oct; 29(10):770-5. PubMed ID: 6508252
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Unusual multiresistant Vibrio cholerae O1 El Tor in Argentina.
    Rossi A; Galas M; Binztein N; Rivas M; Caffer MI; Corso A; Radice M; Gutkind G
    Lancet; 1993 Nov; 342(8880):1172-3. PubMed ID: 7901493
    [No Abstract]   [Full Text] [Related]  

  • 26. Occurrence of transferable multi-drug resistance in Vibrio cholerae-O1 in an endemic area.
    Sundaram SP; Murthy KV
    Indian J Med Res; 1984 Jun; 79():722-7. PubMed ID: 6519698
    [No Abstract]   [Full Text] [Related]  

  • 27. Emergence of multiple drug resistance in Vibrio cholerae O1 El Tor from Ecuador.
    Threlfall EJ; Said B; Rowe B
    Lancet; 1993 Nov; 342(8880):1173. PubMed ID: 7901494
    [No Abstract]   [Full Text] [Related]  

  • 28. [Characterization of a multiresistant strain of Vibrio cholerae O1, isolated from a case of cholera in Chile].
    Castillo L; Ulloa MT; Martínez MA; Silva W; Seoane M; Maldonado A; Castillo P
    Rev Med Chil; 1994 Sep; 122(9):986-92. PubMed ID: 7597345
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cholera vaccine will reduce antibiotic use.
    Okeke IN
    Science; 2009 Aug; 325(5941):674. PubMed ID: 19661401
    [No Abstract]   [Full Text] [Related]  

  • 30. [Comparative in vitro study of antibiotic resistance increase in classical cholera and E1 Tor vibrios].
    Ganin VS; Khundanov LE; Navashin SM
    Antibiotiki; 1971 Sep; 16(9):831-4. PubMed ID: 4333292
    [No Abstract]   [Full Text] [Related]  

  • 31. Cholera epidemic in and around Loni a rural area in western Maharashtra.
    Gujrathi UP; Sivarajan K; Kulkarni SG
    Indian J Pathol Microbiol; 2000 Jan; 43(1):101-2. PubMed ID: 12583433
    [No Abstract]   [Full Text] [Related]  

  • 32. [Vibrio cholerae strains resistant to vibriostatic factor 0/129 isolated from a patient with cholera in Poland].
    Stypułkowska-Misiurewicz H; Gardocka H; Sieczka Z
    Med Dosw Mikrobiol; 1994; 46(4):313-21. PubMed ID: 7603133
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Multiple antibiotic resistance profiles of Vibrio cholerae non-O1 and non-O139.
    Kumar PA; Patterson J; Karpagam P
    Jpn J Infect Dis; 2009 May; 62(3):230-2. PubMed ID: 19468189
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Changing characteristics of Vibrio cholerae: emergence of multidrug resistance and non-O1, non-O139 serogroups.
    Chandrasekhar MR; Krishna BV; Patil AB
    Southeast Asian J Trop Med Public Health; 2008 Nov; 39(6):1092-7. PubMed ID: 19062701
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Prevention of cholera by antibiotics].
    Ermol'eva ZV; Kereselidze TS
    Antibiotiki; 1971 Jun; 16(6):571-3. PubMed ID: 4255832
    [No Abstract]   [Full Text] [Related]  

  • 36. A fatal non-01 Vibrio cholerae septicemia in a patient with liver cirrhosis.
    Eltahawy AT; Jiman-Fatani AA; Al-Alawi MM
    Saudi Med J; 2004 Nov; 25(11):1730-1. PubMed ID: 15573214
    [No Abstract]   [Full Text] [Related]  

  • 37. [Data on biology of nonagglutinating vibrions and their sensitivity to antibiotics].
    Dunaev GS; Zykin LF
    Antibiotiki; 1973 Sep; 18(9):839-44. PubMed ID: 4761957
    [No Abstract]   [Full Text] [Related]  

  • 38. Small-molecule inhibitor of Vibrio cholerae virulence and intestinal colonization.
    Hung DT; Shakhnovich EA; Pierson E; Mekalanos JJ
    Science; 2005 Oct; 310(5748):670-4. PubMed ID: 16223984
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [The chemosensitivity of strains of Vibrio cholerae group O1 isolated in Romania between 1977-1995].
    Israil A; Năcescu N; Cedru C; Balotescu C
    Bacteriol Virusol Parazitol Epidemiol; 1997; 42(4):213-20. PubMed ID: 9586330
    [No Abstract]   [Full Text] [Related]  

  • 40. [Antibiotics. New aspects from the viewpoint of a microbiologist. Assumptions for significant use of antibiotics].
    Traub W
    Fortschr Med; 1974 Jun; 92(16):681-4. PubMed ID: 4599415
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.